Trials / Completed
CompletedNCT00209404
Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- GE Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iodixanol 320 mg I/Ml |
Timeline
- Start date
- 2005-07-01
- First posted
- 2005-09-21
- Last updated
- 2007-10-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00209404. Inclusion in this directory is not an endorsement.